| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.36 | 0.03 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |